Brad Ozenberger, Ph.D., is the genomics program director for the All of Us Research Program, with primary responsibilities in the areas of genetic analysis and data management. Brad is an expert in genomic sequencing and analysis methods. His research emphasis over this decade has been on effective and responsible use of genomic sequencing in medicine. Brad brings a diverse wealth of experience to the program with a career path through the NIH, academia, and industry. Brad was most recently an assistant professor of medicine at the Washington University in St. Louis School of Medicine. Formerly, he served as the deputy director of the Division of Genomic Medicine at the National Human Genome Research Institute, where he directed the Clinical Sequencing Exploratory Research Program supporting investigations of the practical and the psychosocial implications of introducing genome sequencing into clinical practice. He also was co-director of the Cancer Genome Atlas. Prior to joining the NIH, Brad was a distinguished scientist at Wyeth Pharmaceuticals in Princeton, New Jersey. He received a Ph.D. from the University of Missouri School of Medicine and obtained further training as a postdoctoral fellow in the Department of Biology at Yale University.
Program Update | All of Us Marks One Year
(Play video to access audio description)
As the All of Us Research Program marks one year since its national launch, former Director Eric Dishman shares an update and previews what’s coming next for the program. This includes an update on the size and diversity of the health database that All of Us is building for researchers to speed up medical breakthroughs. Eric also announces the launch of the All of Us Research Program’s public Data Browser, which will be a valuable interactive tool for both participants and researchers. Stay tuned for more exciting updates from All of Us by following us on social media and signing up for our newsletter at JoinAllofUs.org .